CAR-T Therapy Target Proteins The chimeric antigen receptor T (CAR-T) cell therapy is a new treatment for a variety of cancers. The idea is to take the T-cells from the patient, and genetically engineer the cells to express a chimeric antigen receptor (CAR) which recognizes a specific tumor- associated antigen (TAA). Creative Biolabs developed an extensive collection of recombinant proteins to support CAR-T therapy development, including full- length protein, partial protein, and made-to-order protein. Please feel free to contact us to learn more products and custom production. CAR-T Therapy Target Full Length Protein CAT# Target Product Name Species Protein Length MP0181X CD19 Magic™ Membrane Protein Human CD19 (CD19 molecule) without tag for Antibody Discovery Human Full Length MP0182X CD19 Magic™ Membrane Protein Human CD19 (CD19 molecule) with GST-tag for Antibody Discovery Human Full Length MP0903J CD22 Magic™ Membrane Protein Human CD22 (CD22 molecule) for Antibody Discovery Human Full Length MP0045Q CD22 Magic™ Membrane Protein Human CD22 (CD22 molecule) expressed in CHO for Antibody Discovery Human Full Length MP0244J CD33 Magic™ Membrane Protein Human CD33 (CD33 molecule) for Antibody Discovery Human Full Length MP0638J CD33 Magic™ Membrane Protein Human CD33 (CD33 molecule) Human Full Length MP0644J CD70 Magic™ Membrane Protein Human CD70 (CD70 molecule) Human Full Length MP0549X IL13RA2 Magic™ Membrane Protein Human IL13RA2 (Interleukin 13 receptor subunit alpha 2) for Antibody Discovery Human Full Length MPC1432K CD19 Magic™ Membrane Protein Human CD19 (CD19 molecule) Full Length Human Full Length MPC4006K CD22 Magic™ Membrane Protein Human CD22 (CD22 molecule) Full Length Human Full Length MPC2061K CD70 Magic™ Membrane Protein Human CD70 (CD70 molecule) Full Length Human Full Length MPC4130K IL13RA2 Magic™ Membrane Protein Human IL13RA2 (Interleukin 13 receptor subunit alpha 2) Full Length Human Full Length DISCOVER MORE CAR-T THERAPY TARGET PRODUCTS MEMBRANE PROTEIN PRODUCTS ©2021 CREATIVE BIOLABS. | WWW.CREATIVE-BIOLABS.COM 13 CAR-T Therapy Target Proteins
phage display library.pdf
May 05, 2023
In vivo Screening: a high throughput method for efficiently isolating tissue-specific binders. The selection is based on binding to target in vivo after the injection of interested phage libraries into whole animals, and then rescuing phage bound to specific organs and tissues.https://www.creative-biolabs.com/phage-display-library-screening.html
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Related Documents
